Print ISSN:-2581-5555

Online ISSN:-2456-9542

CODEN : IIJCDU

Article History

Received : 25-01-2022

Accepted : 28-01-2022



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 2934

PDF Downloaded: 2663


Basics, types and applications of molecular docking: A review


Full Text PDF


Review Article

Author Details : Keval Raval*, Tejas Ganatra

Volume : 7, Issue : 1, Year : 2022

Article Page : 12-16

https://doi.org/10.18231/j.ijcaap.2022.003



Suggest article by email

Get Permission

Abstract

From hit discovery through lead optimization and beyond, computational methods have become an essential part of many drugs development processes. There are typically several steps in the docking process, and each one provides a new level of complexity. Docking methods are used to place small molecules in the active region of the enzyme. In addition to these methods, scoring functions are used to estimate a compound's biological activity by looking at how it interacts with prospective targets. Molecular docking is considered to be the most widely utilized computational phenomenon in the field of computer-aided drug design (CADD). It is being utilized at the academic level as well as in pharmaceutical companies for the lead discovery process. Molecular docking is mainly associated with two terms: ligand and protein. Protein is the target site where ligand may bind to give specific activity. Molecular docking provides information on the ability of the ligand to bind with protein which is known as binding affinity. Applications of molecular docking in drug development have evolved significantly since it was first created to aid in the study of molecular recognition processes between small and large compounds. This review emphasizes the basic features of molecular docking along with the types, approaches and applications.


Keywords: Molecular Docking, Ligand, Molecular Modelling, Lead, Hit



How to cite : Raval K, Ganatra T, Basics, types and applications of molecular docking: A review. IP Int J Compr Adv Pharmacol 2022;7(1):12-16


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.